Close menu




December 29th, 2025 | 07:30 CET

TUI pays dividends again, RE Royalties offers over 10% dividend, Allianz ensures stability – A strong income portfolio

  • royalties
  • Investments
  • Banking
  • dividends
  • travel
Photo credits: pixabay.com

In turbulent markets, savvy investors seek robust income streams that can withstand various economic cycles. The solution lies in a three-pronged approach that intelligently combines cyclical recovery, structural future growth, and defensive stability. This principle can be implemented in concrete terms with three complementary positions: TUI's tourism cash flow, the regenerative royalties of RE Royalties, and Allianz's reliable capital returns.

time to read: 4 minutes | Author: Armin Schulz
ISIN: TUI AG NA O.N. | DE000TUAG505 , RE ROYALTIES LTD | CA75527Q1081 , ALLIANZ SE NA O.N. | DE0008404005

Table of contents:


    TUI – Showing strength: Record profits and a return to dividends

    The 2025 financial year was better than expected for the travel group. Operating profit, measured as adjusted EBIT, increased significantly and exceeded the Company's own forecast. This result was driven primarily by the strong Hotels & Resorts and Cruises segments. Here, higher occupancy rates and fares ensured record levels. Even the Markets + Airline segment, which is undergoing transformation and is under competitive and cost pressure, made a solid contribution to revenue. Overall, earnings per share also climbed sharply.

    The Company has significantly streamlined its finances. Net debt was further reduced, leading to a significant improvement in balance sheet ratios. Rating agencies have also recognized this progress with upgrades. The resulting financial leeway now allows TUI to pursue a new capital expenditure plan. In addition to investments in growth, such as new hotels and ships, the return of funds to shareholders is now back on the agenda.

    This leads to what is likely the most important news for investors: the return to dividends. An introductory dividend is proposed for 2025. From the coming fiscal year onwards, a reliable portion of earnings per share is to be distributed. This combined strategy of growth investments and shareholder remuneration has been met with widespread approval by analysts. Many see the positive operating performance and strengthened balance sheet as the foundation for further share price growth, even if some are critical of the moderate growth outlook for 2026. The share is currently trading at EUR 9.196.

    RE Royalties – With a financing model for the energy transition

    RE Royalties has established a business model that aims to combine stability with growth. The Company provides capital to project developers in the renewable energy sector. In return, it does not receive any company shares, but contractually agreed shares in the projects' revenues, known as royalties. This approach generates recurring cash flows linked to long-term power purchase agreements. The portfolio includes solar, wind, and storage projects in several countries, aiming for broad risk diversification.

    On December 11, the Company reported several operational advances, with the focus set on developing new projects. Most recently, letters of intent totaling approximately CAD 50 million were signed for various short-term projects. Due diligence is currently underway. At the same time, existing financing for a solar and storage portfolio was extended by one year, and the terms improved. In addition, the repayment of an initial green bond issue of CAD 10 million has been largely completed. The final installment of CAD 300,000 is due in the first quarter of 2026. This is complemented by the appointment of an experienced financing expert to the Board of Directors and an additional listing in Frankfurt to increase the reach among investors.

    The distribution policy is being readjusted. A dividend payment of CAD 0.01 per share has been declared again for January 2026. In the future, however, the Company intends to switch from quarterly to annual distributions. This decision is aimed at maintaining greater financial flexibility in order to be able to take advantage of high-growth investment opportunities more quickly. Extrapolated to a full year, the previous CAD 0.01 quarterly dividend would total CAD 0.04, implying a current yield of over 15%. The long-term dividend capacity is to be strengthened by temporarily retaining capital to finance the promising project pipeline.

    The share is currently trading at CAD 0.26.

    Watch YouTube video

    Allianz - Scores with strong figures and new partnerships

    Allianz is in robust shape after nine months. Operating profit rose sharply and reached a record high. In light of this strong performance, the Management Board has revised its forecast for the full year upwards. It now expects operating profit to be at the upper end of the original target range. Provided there are no unforeseeable major loss events, the final result is likely to be slightly higher than this. This development underscores the Group's stable operating performance in all core segments.

    In addition to the solid quarterly figures, the Company has launched a strategic initiative. Together with the investment firm Oaktree, it is establishing a new syndicate at Lloyd's of London. This partnership secures Allianz's long-term, highly rated reinsurance capacity. The move enables the Company to take advantage of capital market trends and tap into innovative forms of risk transfer. It is a logical move to further strengthen the resilience of the portfolio and respond flexibly to market opportunities.

    Capital returns remain a key issue for shareholders. The dividend policy provides for a reliable distribution of a large portion of adjusted earnings, with the level of the previous year's dividend of EUR 15.40 being maintained at a minimum. This basis is supplemented by additional measures such as share buybacks. This combined strategy aims to offer attractive overall returns even in volatile phases. Dividend continuity is supported by solid capital resources and stable earnings power. The share price is currently trading at EUR 391.10.


    The combination of cyclical recovery, structural growth, and defensive stability forms a robust earnings portfolio. TUI is rewarding shareholders after restructuring with a return to dividends. RE Royalties offers promising growth and a very high dividend yield with its royalty model for renewable energy. Allianz ensures fundamental stability in the portfolio with record-breaking results and predictable capital returns.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Armin Schulz

    Armin Schulz

    Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read